NIH-funded post-doctoral positions are available within the Lovly lab team for highly motivated, enthusiastic, hard-working individuals to conduct translational lung cancer research.
|Hematology and Oncology
The Lovly laboratory at Vanderbilt University Medical Center is a translational research team focused on understanding and developing improved therapeutic strategies for clinically relevant molecular subsets of lung cancer. Our overarching goal is to accelerate discoveries and develop new treatment paradigms for patients with lung cancer. We utilize cutting edge single cell genomic and proteomic techniques to understand the role of genomic and non-genomic factors which mediate drug response and resistance. Key projects are focused on identifying mediators of intrinsic and acquired resistance to targeted therapies in lung cancer, deciphering structural, biochemical, and molecular mechanisms of oncogenesis of tumor associated mutations, utilizing cell free DNA to monitor the evolution of lung cancer, and characterizing the genomics and immune contexture of small cell lung cancer.
To apply, please send:
Or, for more information, please contact the PI directly. Thank you for your interest!